XML 54 R38.htm IDEA: XBRL DOCUMENT v3.20.4
Share-Based Compensation and Benefit Plans (Tables)
12 Months Ended
Dec. 31, 2020
Share-Based Compensation and Benefit Plans  
Summary of shares authorized and available for future issuance under compensation and benefit plans

December 31, 2020

    

Total Shares Authorized for

    

Shares Available for Future

Plans

Issuance under the Plans

Issuance under the Plans

Incentive Plans

 

34,650

 

5,592

Employee Stock Purchase Plan

 

4,250

 

506

Profit Sharing and Savings Plan

 

4,200

 

349

Restricted stock [Member]  
Share-Based Compensation and Benefit Plans  
Summary of activity of share-based compensation and benefit plans

For the Year Ended

December 31, 

    

2020

    

2019

    

2018

Compensation expense for restricted shares awarded

$

1,488

$

1,387

$

1,370

Income tax benefit from compensation expense related to restricted shares

$

373

$

341

$

340

Total fair value of restricted shares at vest date

$

1,591

$

1,633

$

1,230

Shares awarded under the plans

 

4

 

4

 

5

Weighted-average grant-date fair value of shares awarded under the plans

$

412.67

$

355.91

$

263.89

Employee stock purchase plan [Member]  
Share-Based Compensation and Benefit Plans  
Summary of ESPP plan activity

For the Year Ended

December 31, 

    

2020

    

2019

    

2018

Compensation expense for shares issued under the ESPP

$

2,824

$

2,490

$

2,285

Income tax benefit from compensation expense related to shares issued under the ESPP

$

708

$

612

$

566

Shares issued under the ESPP

 

45

 

43

 

53

Weighted-average price of shares issued under the ESPP

$

353.04

$

329.69

$

245.26

Employee [Member] | Restricted stock [Member]  
Share-Based Compensation and Benefit Plans  
Summary of restricted stock

Weighted-Average Grant-Date

    

Shares

    

Fair Value

Non-vested at December 31, 2019

 

4

$

301.40

Granted during the period

 

2

 

419.88

Vested during the period (1)

 

(2)

 

289.03

Forfeited during the period

 

 

Non-vested at December 31, 2020

 

4

$

358.58

Director [Member] | Restricted stock [Member]  
Share-Based Compensation and Benefit Plans  
Summary of restricted stock

Weighted-Average Grant-Date

    

Shares

    

Fair Value

Non-vested at December 31, 2019

 

4

$

312.96

Granted during the period

 

2

 

407.12

Vested during the period

 

(2)

 

293.72

Forfeited during the period

 

 

Non-vested at December 31, 2020

 

4

$

371.46

Stock option [Member]  
Share-Based Compensation and Benefit Plans  
Black-Scholes option pricing model

December 31, 

    

2020

2019

2018

Risk free interest rate

 

0.86

%  

2.26

%  

2.63

%

Expected life

 

5.9

Years

5.7

Years

5.9

Years

Expected volatility

 

26.4

%  

25.1

%  

24.0

%

Expected dividend yield

 

%  

%  

%

Summary of activity of share-based compensation and benefit plans

For the Year Ended

December 31, 

    

2020

2019

2018

Compensation expense for stock options awarded (in thousands)

$

18,435

$

18,044

$

16,521

Income tax benefit from compensation expense related to stock options (in thousands)

 

4,620

 

4,436

 

4,093

Total intrinsic value of stock options exercised (in thousands)

 

79,451

 

117,489

 

156,327

Cash received from exercise of stock options (in thousands)

 

46,282

 

46,106

 

61,403

Weighted-average grant-date fair value of options awarded

$

106.76

$

105.37

$

76.57

Weighted-average remaining contractual life of exercisable options (in years)

 

4.5

 

4.6

 

4.4

Stock option [Member] | Employee stock option [Member]  
Share-Based Compensation and Benefit Plans  
Summary of stock options

    

    

    

Average

    

Aggregate

Shares

Weighted- Average

Remaining

Intrinsic Value

(in thousands)

Exercise Price

Contractual Terms

(in thousands)

Outstanding at December 31, 2019

 

1,635

$

218.10

 

  

 

  

Granted

 

175

 

394.79

 

  

 

  

Exercised

 

(288)

 

160.67

 

  

 

  

Forfeited or expired

 

(22)

 

302.55

 

  

 

  

Outstanding at December 31, 2020

 

1,500

$

248.52

 

5.7

Years

$

306,095

Vested or expected to vest at December 31, 2020

 

1,470

$

246.44

 

5.7

Years

$

302,927

Exercisable at December 31, 2020

 

988

$

202.19

 

4.5

Years

$

247,419